First Hypertension Drug to Inhibit Kidney Enzyme Approved
TUESDAY, March 6 (HealthDay News) — Tekturna, a new molecular entity that acts at the earlier stages of the blood pressure regulation process to inhibit hypertension, has been approved by the U.S. Food and Drug Administration.
